Home › Funds › HARDING LOEVNER LP › ELV

HARDING LOEVNER LP position in ELV

ELEVANCE HEALTH INC FORMERLY · Health Care

HARDING LOEVNER LP reported holding 168,707 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q2 2026 13F filing — a position valued at US$65.2M, representing 0.61% of its reported portfolio and ranking #44 among its reported holdings. HARDING LOEVNER LP has disclosed ELV holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)168.71K sh
Reported value held$65.24M
Portfolio Weight0.61%
First reportedQ3 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How HARDING LOEVNER LP's ELV position evolved

HARDING LOEVNER LP first disclosed a stake in ELV in Q3 2025 at 246,365 shares (US$79.6M). Across 4 filings, HARDING LOEVNER LP increased the stake 0 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 168,707 shares valued at US$65.2M — a reduction of -43,132 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2025 246.37K $79.61M New
Q4 2025 220.72K $77.38M Reduce
Q1 2026 211.84K $62.03M Reduce
Q2 2026 168.71K $65.24M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELV and 13F data

ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.25B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELV

All ELV fund holders →

FAQ

How long has HARDING LOEVNER LP held ELV?

HARDING LOEVNER LP has disclosed ELV holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is HARDING LOEVNER LP's current position in ELV?

As of Q2 2026, HARDING LOEVNER LP holds 168.71K shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $65.24M, representing 0.61% of its reported portfolio and ranking #44.

Has HARDING LOEVNER LP been buying or selling ELV?

In the latest 13F filing (Q2 2026), HARDING LOEVNER LP reduced its position in ELV.

Which other funds hold ELV?

Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.